|
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT
|
Sep 2016
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes.
|
Sep 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function
|
Apr 2014
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Efficacy and safety of deferasirox in myelodysplastic syndromes
|
Feb 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia
|
Aug 2017
|
Ann Hematol
|
aplastic anemia
|
|
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab
|
Jan 2017
|
Ann Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II
|
Nov 2016
|
Ann Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.
|
May 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in Argentinean patients
|
Jul 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability.
|
May 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
